BioWorld Science

March 13, 2008

View Archived Issues

Recent patent literature discloses novel antibacterial agents

Read More

New therapeutic agents for obesity and other metabolic disorders described in recent patents

Read More

Novel therapeutic agents for HIV infection reported in a recent patent

Read More

Maruzen imparts novel agents for dermatological disorders in a recent patent

Read More

Experiments clarify antidepressant activity of ketamine

Read More

Significant antimanic effects observed with tamoxifen in a randomized trial

Read More

FDA accepts Pipex's IND application to conduct phase II clinical trial of oral flupirtine

Read More

Nventa initiates dosing in final cohort of phase I trial of HspE7

Read More

iCo Therapeutics presents a clinical update on human monoclonal antibody iCo-008

Read More

Anavex reports results from preclinical studies of cancer drug Anavex 7-1037

Read More

Symbollon signs term sheet to acquire MedPharm for USD 1.5 million

Read More

EUSA Pharma to acquire Cytogen for USD 22.6 million in cash

Read More

EMEA grants Clinuvel two orphan drug designations for CUV-1647

Read More

Percutaneous Loxonin Tape receives Japanese marketing approval

Read More

Novartis submits Rasilez for approval in Japan

Read More

CRx-191 demonstrates positive phase II results in psoriasis

Read More

Nymox reports results from U.S. NX-1207 study in benign prostatic hyperplasia

Read More

XenoPort presents positive phase I results with XP-21279

Read More

Bionovo reports support for MF-101 from two independent physician surveys

Read More

Ortho Biotech to defend the safety of Procrit and ESAs at meeting with the ODAC

Read More

Avicena's HD-02 to enter NIH-sponsored phase III trial in HD

Read More

Calistoga Pharmaceuticals begins first clinical trial of novel oral PI3K delta inhibitor

Read More

FDA accepts Arisaph's IND application to evaluate ARI-2243 in phase I clinical trial

Read More